The cost of employer-sponsored health insurance rose for the third year in a row in 2025, approaching an average of almost $27,000 for a family plan, according to an annual survey from KFF released ...

Research has suggested the potential of GLP-1 medications for treating substance use disorders, including alcohol, opioids, ...

The U.S. adult obesity rate, calculated as having a BMI of 30 or higher, has gradually declined to 37% in 2025, dropping from ...

The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, ...

GLP-1s hold promise as a potential treatment for alcohol and substance use disorders, according to an expert endocrine ...

Founder Jenna Owens shares how she's pivoting the company she launched as a CBD-focused beauty line and moving into telehealth amid a shifting wellness industry.

Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch next year.

A science-backed natural supplement that can help you reach your weight loss goals, especially if a GLP-1s is not an option.

Agentic artificial intelligence took center stage at the HLTH 2025 conference in Las Vegas, and Brigham Hyde, Ph.D., is ...

Although findings from a large retrospective study supports these positive effects of taking a GLP-1, it’s unclear whether ...

The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity ...